Heading the triple combination therapy!? Treatment results in retreated patients with hepatitis C (G1)
M Varga, K Csefkó, I Nagy, A Pálvölgyi, T Martyin, P Lakatos, B Lombay, Z Váczi, A Tusnádi, M Lesch, B Sipos, A Budai, G Weisz, V Jancsik, I Tornai · Zeitschrift für Gastroenterologie · 2011 · Heft 05
Bibliografische Angaben
Zusammenfassung
Goal and method: Triple therapy combined with protease inhibitors will be available soon in our country. On the other hand it is still not clear, which factors are the most important in therapeutic success. 1237 patients were treated with hepatitis C in 11 centers of East Hungary between 2004 and 2008. In our retrospective analysis we processed the data of 970 interferon naiv and 367 earlier treated patients. In our lecture we state the data of retreated patients and survey the data of nonresponder patients in order to find the reasons of therapeutic failure. Patients were treated with PEGIFN alfa2a + RBV or PEG…
